Further, prospective studies measuring circulating melanoma cells in 230 patients with melanoma and 152 healthy controls identified two other potential prognostic serological CTC markers; MLANA, a melanocyte marker, and ABCB5, a stem-like cell marker [31]. This evidence concerns the gene ABCB5 and melanoma.